All In Biotech

Drug Trial Radar · NCT02258074

The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE

Last checked: Nov 20, 2026Latest source record: Aug 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 205 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

205

Actual

Start

Mar 2015

Primary completion

Nov 2018

Study completion Sep 2019

Sponsor

Lead sponsor
The Cleveland ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First posted
Oct 7, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The COMBINE clinical trial is a pilot study evaluating the effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor 23 (FGF23) in patients with Chronic Kidney Disease (CKD) stages 3-4.

Conditions

  • Chronic Kidney Disease

Interventions

  • NicotinamideDrug

  • Lanthanum CarbonateDrug

  • Placebo (for Nicotinamide)Drug

    Sugar pill manufactured to mimic Nicotinamide 750 mg capsule

  • Placebo (for lanthanum carbonate)Drug

    Sugar pill manufactured to mimic Lanthanum Carbonate 500 mg capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. FGF23Time frame: Baseline to 12 months
  2. Serum Phosphate (mg/dl)Time frame: Baseline to 12 months

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • University of California at San Diego

    San Diego, California

  • Denver Nephrology Research

    Denver, Colorado

  • George Washington University

    Washington D.C., District of Columbia

  • NorthShore University Health System

    Chicago, Illinois

  • Northwestern University

    Chicago, Illinois

  • University of Utah

    Salt Lake City, Utah

  • Utah VA

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.